Earningsreport

Q1/2023 3/31/2023 EPS -0.640 ZacksConsensus -0.590 ActVsEst (0.050) - Miss

Cocrystal Pharma, Inc.  (COCP) 
NASDAQ:AMEX Investor Relations: cocrystalpharma.com